Wolfe Research analyst Justin Lake reiterated a Peer Perform rating on Centene (CNC) after the company announced the withdrawal of 2025 guidance driven by significant pressure in its health insurance business and the elevated cost trend in Medicaid. The firm lowered its EPS estimates for 2025 and 2026 with the expectation that in addition to HIX pressure, Medicaid pressure is unlikely to be offset by Medicare/SG&A given Medicaid is a much larger business. Wolfe added that it would not be a buyer on Wednesday’s weakness given uncertainty in 2026.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNC: